{
    "nctId": "NCT01553097",
    "briefTitle": "Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty",
    "officialTitle": "Neurocognitive Impairment in Women With Early Stage Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Neurocognitive Impairment, Quality of Life",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 51,
    "primaryOutcomeMeasure": "test neurocognitive function, using CNSVS, of the three groups while adjusting for fatigue, perceived stress, and depressive symptoms.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* read and speak English\n* be physically able to take the computerized test (press the keyboard space bar and numerical keys \"1\" and \"2\" without difficulty)\n* have an ECOG Performance Status score \\< 2.154\n* capable of providing informed consent.\n\nExclusion Criteria:\n\n* psychiatric impairment, such as organic brain disorders, mental retardation, active psychoses or dissociative disorders, or unstable and/or severe depressive illness.",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}